The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; Clovis Oncology; CureVac; Eisai; Genomic Health; ImmunoMedics (Inst); Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Pharmamab; Roche/Genentech; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Celgene; CureVac; Eisai; Genomic Health; Immunomedics (Inst); Janssen-Cilag; Novartis; Pfizer; Roche (Inst); Tesaro; Vaccibody (Inst)
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Tesaro (Inst); Vaccibody (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; PharmaMar; Roche
PARSIFAL: A randomized, multicenter, open-label, phase II trial to evaluate palbociclib in combination with fulvestrant or letrozole in endocrine-sensitive patients with estrogen receptor (ER)[+]/HER2[-] metastatic breast cancer.
 
Antonio Llombart-Cussac
Leadership - Celgene; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
Stock and Other Ownership Interests - Initia-Research; MedSIR
Consulting or Advisory Role - Genomic Health; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - AstraZeneca; Lilly; MSD
Research Funding - Agendia; Foundation Medicine; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; Pfizer; Roche
 
José Manuel Pérez-García
Consulting or Advisory Role - Lilly; Roche
Travel, Accommodations, Expenses - Roche
 
Meritxell Bellet
Honoraria - Lilly; Novartis; Pfizer
Consulting or Advisory Role - Lilly; Novartis; Pfizer
Speakers' Bureau - Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Pfizer; Roche
 
Florence Dalenc
No Relationships to Disclose
 
Miguel J. Gil Gil
Honoraria - Eisai; Novartis; Pfizer
Consulting or Advisory Role - Agendia; Daiichi Sankyo; Genomic Health
Travel, Accommodations, Expenses - Daiichi Sankyo; Kern Pharma; Pfizer; Roche
 
Manuel Ruiz Borrego
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche
 
Joaquín Gavilá
Honoraria - Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; MSD; Novartis; Pfizer
Speakers' Bureau - Novartis; Pfizer
Travel, Accommodations, Expenses - Roche
 
Miguel Sampayo-Cordero
Honoraria - MedSIR; Nestle Health Science; Syntax for Science
Consulting or Advisory Role - MedSIR; Nestle Health Science; Syntax for Science
Speakers' Bureau - MedSIR; Roche; Syntax for Science
Research Funding - MedSIR; Roche; Syntax for Science
Travel, Accommodations, Expenses - MedSIR; Roche; Syntax for Science
 
Elena Aguirre
Consulting or Advisory Role - AstraZeneca; MSD; Pfizer; Roche
 
Peter Schmid
Employment - Genentech (I); Roche (I)
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); Oncogenex (Inst); Roche (Inst)
 
Frederik Marmé
No Relationships to Disclose
 
Serena Di Cosimo
No Relationships to Disclose
 
Joseph Gligorov
Consulting or Advisory Role - Daiichi Sankyo; Eisai; Genomic Health; Immunomedics; Ipsen; Macrogenics; Merck Sharp & Dohme; Mylan; Novartis; Onxeo; Pfizer; Roche
Speakers' Bureau - Eisai; Genomic Health; Ipsen; Merck Sharp & Dohme; Mylan; Novartis; Pfizer; Roche
Research Funding - Eisai; Genomic Health; Roche
Travel, Accommodations, Expenses - Eisai; Genomic Health; Merck Sharp & Dohme; Mylan; Novartis; Pfizer; Roche
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Tesaro
Research Funding - Abbvie; Celgene (Inst); Molecular Partners; Roche Pharma AG (Inst)
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Joan Albanell
Consulting or Advisory Role - Amgen; Lilly; MSD; Pfizer; Roche
Speakers' Bureau - Pfizer; Roche
Research Funding - Roche (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Biomarti
Travel, Accommodations, Expenses - Amgen; Lilly; MSD; Pfizer; Roche
 
Pilar Zamora
Research Funding - Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Duncan Wheatley
Honoraria - AstraZeneca; Lilly; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Novartis; pfizer; Roche
Travel, Accommodations, Expenses - Lilly; Roche
 
Eduardo Martínez-De Dueñas
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Roche
 
Kepa Amillano
No Relationships to Disclose
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Daiichi Sankyo; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Athenex; Bioasis; Biothera; Celgene; Cellestia Biotech; Clovis Oncology; Daiichi Sankyo; ERYTECH Pharma; GlaxoSmithKline; Leuko; Lilly; Merck Sharp & Dohme; Merus; Polyphor; Roche; Seagen; SERVIER
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Piqur (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Eisai; Novartis; Pfizer; Roche